Patterns of initial and first-intensifying antidiabetic drug utilization among patients with type 2 diabetes mellitus in Scotland, 2010-2020: A retrospective population-based cohort study.

Fatema MahmoudTanja MuellerAlexander MullenChristopher A R SainsburyGordon F RushworthAmanj Baker Kurdi

Published in: Diabetes, obesity & metabolism (2024)

An overall increasing trend in prescribing the newer ADD classes compared to older ADDs was observed. However, metformin remained the most commonly prescribed first-line ADD, while SGLT2 inhibitors replaced SUs as the most common add-on therapy to initial metformin use in 2019.

Keyphrases

primary care
adverse drug
physical activity
emergency department
middle aged
stem cells
mesenchymal stem cells
bone marrow
cell therapy